Cargando…
Probiotics for the Prevention of Antibiotic-Associated Diarrhea
Several communities have started using probiotic-rich fermented foods as therapeutic options with presumed medicinal powers. We now know the importance of microbiome balance and how probiotics can restore imbalances in the microbiome. Probiotics have been tested for a number of clinical uses such as...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408191/ https://www.ncbi.nlm.nih.gov/pubmed/36011108 http://dx.doi.org/10.3390/healthcare10081450 |
_version_ | 1784774546963824640 |
---|---|
author | Kopacz, Kira Phadtare, Sangita |
author_facet | Kopacz, Kira Phadtare, Sangita |
author_sort | Kopacz, Kira |
collection | PubMed |
description | Several communities have started using probiotic-rich fermented foods as therapeutic options with presumed medicinal powers. We now know the importance of microbiome balance and how probiotics can restore imbalances in the microbiome. Probiotics have been tested for a number of clinical uses such as the prevention of antibiotic-associated diarrhea (AAD), the treatment of various diseases such as H. pylori infection, irritable bowel disease, vaginitis, the prevention of allergies, and necrotizing enterocolitis in newborns. AAD has been the most indicated therapeutic use for probiotics. AAD is a common side effect of antibiotic usage, which affects up to 30% of patients. The hypothesis behind using probiotics for AAD is that they help normalize an unbalanced flora. There are many potential mechanisms by which probiotics support intestinal health such as (i) boosting immunity, (ii) increasing gut barrier integrity, (iii) producing antimicrobial substances, (iv) modulating the gut microbiome, (v) increasing water absorption, and (vi) decreasing opportunistic pathogens. Many randomized-controlled trials including the strain-specific trials that use Lactobacillus and Saccharomyces and meta-analyses have shown the benefits of probiotics in addressing AAD. Although adverse events have been reported for probiotics, these are broadly considered to be a safe and inexpensive preventative treatment option for AAD and other gastrointestinal disorders. |
format | Online Article Text |
id | pubmed-9408191 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94081912022-08-26 Probiotics for the Prevention of Antibiotic-Associated Diarrhea Kopacz, Kira Phadtare, Sangita Healthcare (Basel) Review Several communities have started using probiotic-rich fermented foods as therapeutic options with presumed medicinal powers. We now know the importance of microbiome balance and how probiotics can restore imbalances in the microbiome. Probiotics have been tested for a number of clinical uses such as the prevention of antibiotic-associated diarrhea (AAD), the treatment of various diseases such as H. pylori infection, irritable bowel disease, vaginitis, the prevention of allergies, and necrotizing enterocolitis in newborns. AAD has been the most indicated therapeutic use for probiotics. AAD is a common side effect of antibiotic usage, which affects up to 30% of patients. The hypothesis behind using probiotics for AAD is that they help normalize an unbalanced flora. There are many potential mechanisms by which probiotics support intestinal health such as (i) boosting immunity, (ii) increasing gut barrier integrity, (iii) producing antimicrobial substances, (iv) modulating the gut microbiome, (v) increasing water absorption, and (vi) decreasing opportunistic pathogens. Many randomized-controlled trials including the strain-specific trials that use Lactobacillus and Saccharomyces and meta-analyses have shown the benefits of probiotics in addressing AAD. Although adverse events have been reported for probiotics, these are broadly considered to be a safe and inexpensive preventative treatment option for AAD and other gastrointestinal disorders. MDPI 2022-08-02 /pmc/articles/PMC9408191/ /pubmed/36011108 http://dx.doi.org/10.3390/healthcare10081450 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Kopacz, Kira Phadtare, Sangita Probiotics for the Prevention of Antibiotic-Associated Diarrhea |
title | Probiotics for the Prevention of Antibiotic-Associated Diarrhea |
title_full | Probiotics for the Prevention of Antibiotic-Associated Diarrhea |
title_fullStr | Probiotics for the Prevention of Antibiotic-Associated Diarrhea |
title_full_unstemmed | Probiotics for the Prevention of Antibiotic-Associated Diarrhea |
title_short | Probiotics for the Prevention of Antibiotic-Associated Diarrhea |
title_sort | probiotics for the prevention of antibiotic-associated diarrhea |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408191/ https://www.ncbi.nlm.nih.gov/pubmed/36011108 http://dx.doi.org/10.3390/healthcare10081450 |
work_keys_str_mv | AT kopaczkira probioticsforthepreventionofantibioticassociateddiarrhea AT phadtaresangita probioticsforthepreventionofantibioticassociateddiarrhea |